Tandem Diabetes Care, Inc. (TNDM) Gross Margin
- Gross margin · 12 months: Value 56.01%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 56.01% | Gross profit / revenue. Period ending 2026-06-30. $583.32M ÷ $1.04B × 100 ≈ 56.01% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 583.32M USD | Gross Profit |
| Revenue | 1.04B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 458.10M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $583.32M | $1.04B | $458.10M | 56.01% |
| 2026-03-31 | $564.39M | $1.03B | $463.14M | 54.93% |
| 2025-12-31 | $546.01M | $1.01B | $468.72M | 53.81% |
| 2025-09-30 | $536.01M | $1.01B | $470.99M | 53.23% |
| 2025-06-30 | $526.37M | $1.00B | $475.35M | 52.55% |
| 2025-03-31 | $513.31M | $982.95M | $469.64M | 52.22% |
| 2024-12-31 | $489.57M | $940.20M | $450.63M | 52.07% |
| 2024-09-30 | $425.41M | $854.35M | $428.94M | 49.79% |
| 2024-06-30 | $390.51M | $796.00M | $405.49M | 49.06% |
| 2024-03-31 | $379.45M | $770.01M | $390.55M | 49.28% |
| 2023-12-31 | $367.69M | $747.72M | $380.03M | 49.17% |
| 2023-09-30 | $389.92M | $771.42M | $381.51M | 50.55% |
| 2023-06-30 | $404.59M | $790.35M | $385.76M | 51.19% |
| 2023-03-31 | $404.80M | $794.69M | $389.89M | 50.94% |
| 2022-12-31 | $412.99M | $801.22M | $388.23M | 51.54% |
| 2022-09-30 | $411.19M | $790.71M | $379.52M | 52.00% |
| 2022-06-30 | $403.51M | $765.79M | $362.28M | 52.69% |
| 2022-03-31 | $394.02M | $737.67M | $343.65M | 53.41% |
| 2021-12-31 | $376.21M | $702.80M | $326.58M | 53.53% |
| 2021-09-30 | $353.04M | $660.87M | $307.83M | 53.42% |
| 2021-06-30 | $321.61M | $604.84M | $283.23M | 53.17% |
| 2021-03-31 | $283.55M | $541.94M | $258.39M | 52.32% |
| 2020-12-31 | $260.52M | $498.83M | $238.31M | 52.23% |
| 2020-09-30 | $230.24M | $439.16M | $208.93M | 52.43% |
| 2020-06-30 | $215.61M | $410.22M | $194.61M | 52.56% |
| 2020-03-31 | $211.12M | $394.24M | $183.12M | 53.55% |
| 2019-12-31 | $194.21M | $362.31M | $168.09M | 53.60% |
| 2019-09-30 | $175.48M | $330.11M | $154.63M | 53.16% |
| 2019-06-30 | $146.59M | $281.71M | $135.13M | 52.03% |
| 2019-03-31 | $111.77M | $222.58M | $110.81M | 50.22% |
| 2018-12-31 | $89.82M | $183.87M | $94.04M | 48.85% |
| 2018-09-30 | $65.75M | $147.96M | $82.21M | 44.44% |
| 2018-06-30 | $55.83M | $128.70M | $72.87M | 43.38% |
| 2018-03-31 | $48.74M | $115.90M | $67.16M | 42.06% |
| 2017-12-31 | $44.09M | $107.60M | $63.51M | 40.98% |
| 2017-09-30 | $36.69M | $96.22M | $59.53M | 38.13% |
| 2017-06-30 | $23.24M | $81.51M | $58.27M | 28.51% |
| 2017-03-31 | $23.42M | $83.17M | $59.75M | 28.16% |
| 2016-12-31 | $23.59M | $84.25M | $60.66M | 28.00% |
| 2016-09-30 | $26.99M | $84.46M | $57.47M | 31.95% |
| 2016-06-30 | $34.08M | $87.88M | $53.80M | 38.78% |
| 2016-03-31 | $30.70M | $80.60M | $49.90M | 38.09% |
| 2015-12-31 | $26.58M | $72.85M | $46.27M | 36.49% |
| 2015-09-30 | $19.66M | $61.62M | $41.96M | 31.90% |
| 2015-06-30 | $18.54M | $59.42M | $40.88M | 31.21% |
| 2015-03-31 | $17.19M | $53.97M | $36.77M | 31.85% |
| 2014-12-31 | $15.25M | $49.72M | $34.47M | 30.67% |
| 2014-09-30 | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) |
| 2013-12-31 | $6.17M | $29.01M | $22.84M | 21.26% |
| 2013-09-30 | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) |
| 2012-12-31 | $-1.35M | $2.48M | $3.82M | -54.46% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |